SNY FY 2016 Earnings Report — Sanofi Revenue & Financial Results | Market Cap Arena

FY 2016 Earnings

Reported December 30, 2016

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2016	Prior Q	FY 2015	QoQ Change	YoY Change
Revenue	$40.6B	—	$40.8B	—	-0.5%
Op. Income	$7.6B	—	$6.6B	—	16.1%
Gross Margin	69.2%	—	68.7%	—	0.5pp
Net Margin	13.6%	—	12.3%	—	1.3pp
EPS (Diluted)	$2.14	—	$1.92	—	11.6%
Free Cash Flow	$6.7B	—	$7.2B	—	-6.4%

Revenue Flow

Item	Amount
REVENUE	$40.6B
Cost of Revenue	$12.5B
GROSS PROFIT	$28.1B
R&D Expenses	$6.1B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$11.1B
Other Expenses	$3.3B
Operating Expenses	$20.4B
Cost & Expenses	$33.0B
OPERATING INCOME	$7.6B
Interest Income	$69M
Interest Expense	$468M
Other Income/Expenses	-$843M
INCOME BEFORE TAX	$6.8B
Income Tax Expense	$1.6B
Net Income from Continuing Ops	$5.3B
Net Income from Discontinued Ops	$368M
Other Adjustments	$0
NET INCOME	$5.5B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.5B
D&A	$3.9B
EBIT	$7.7B
EBITDA	$11.6B
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$40.6B
Cost of Revenue	$12.5B
GROSS PROFIT	$28.1B
R&D Expenses	$6.1B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$11.1B
Other Expenses	$3.3B
Operating Expenses	$20.4B
Cost & Expenses	$33.0B
OPERATING INCOME	$7.6B
Interest Income	$69M
Interest Expense	$468M
Other Income/Expenses	-$843M
INCOME BEFORE TAX	$6.8B
Income Tax Expense	$1.6B
Net Income from Continuing Ops	$5.3B
Net Income from Discontinued Ops	$368M
Other Adjustments	$0
NET INCOME	$5.5B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.5B
D&A	$3.9B
EBIT	$7.7B
EBITDA	$11.6B
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$5.5B
Depreciation & Amortization	$3.9B
Stock-Based Compensation	$293M
Deferred Income Tax	-$635M
Other Non-Cash Items	-$536M
Change in Working Capital	$970M
OPERATING CASH FLOW	$9.2B
Capital Expenditure	-$2.4B
Acquisitions (Net)	-$499M
Purchases of Investments	-$244M
Sales/Maturities of Investments	$0
Other Investing Activities	$241M
NET CASH FROM INVESTING	-$2.9B
Net Debt Issuance	$2.7B
Common Stock Repurchased	-$3.4B
Common Dividends Paid	-$4.4B
Other Financing Activities	$320M
NET CASH FROM FINANCING	-$4.8B
FREE CASH FLOW	$6.7B
Net Change in Cash	$1.3B

Balance Sheet

Item	Amount
Cash & Equivalents	$12.0B
Short-Term Investments	$126M
Net Receivables	$10.6B
Inventory	$8.1B
Other Current Assets	$36M
TOTAL CURRENT ASSETS	$31.2B
PP&E (Net)	$11.7B
Goodwill	$47.2B
Intangible Assets	$12.7B
Long-Term Investments	$6.7B
Tax Assets	$5.5B
Other Non-Current Assets	$7.6B
TOTAL NON-CURRENT ASSETS	$91.3B
TOTAL ASSETS	$122.6B
Account Payables	$5.0B
Short-Term Debt	$2.1B
Deferred Revenue	$0
Other Current Liabilities	$8.5B
TOTAL CURRENT LIABILITIES	$19.2B
Long-Term Debt	$19.6B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$2.7B
Other Non-Current Liabilities	$13.4B
TOTAL NON-CURRENT LIABILITIES	$35.7B
TOTAL LIABILITIES	$55.0B
Common Stock	$3.0B
Additional Paid-In Capital	$0
Retained Earnings	$60.3B
Treasury Stock	-$1.8B
Accum. Other Comp. Income	$5.9B
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$67.4B
Minority Interest	$199M
TOTAL EQUITY	$67.6B
TOTAL LIABILITIES & EQUITY	$122.6B
Total Debt	$21.8B
Net Debt	$9.7B